Raltitrexed, CAS [[112887-68-0]]
Artikelnummer:
BYT-ORB1300600
Produktübersicht
Artikelname:
Raltitrexed, CAS [[112887-68-0]]
Artikelnummer:
BYT-ORB1300600
Hersteller Artikelnummer:
orb1300600
Alternativnummer:
BYT-ORB1300600-1,BYT-ORB1300600-10,BYT-ORB1300600-100,BYT-ORB1300600-200,BYT-ORB1300600-25,BYT-ORB1300600-5,BYT-ORB1300600-50
Hersteller:
Biorbyt
Kategorie:
Biochemikalien
Alternative Synonym:
inhibit, Nucleoside Antimetabolite, NucleosideAntimetabolite, Nucleoside Antimetabolite/Analog, Inhibitor, ICI-D 1694, ICI-D1694, ICI-D-1694, Analog, DNASynthesis, DNA Synthesis, D 1694, D1694, D-1694, Thymidylate Synthase, Thymidylate synthase, Raltitrexed, ZD 1694, ZD1694, ZD-1694, Tomudex, RNA Synthesis, RNASynthesis
Produktbeschreibung
Raltitrexed (D1694) is a potent thymidylate synthase inhibitor with an IC50 of 9 nM, effectively suppressing L1210 leukemia cell growth in vitro. It is widely used in cancer research, including studies on colorectal carcinoma, both in cellular assays and in vivo models.
Produkteigenschaften
Molekulargewicht:
458.49
Reinheit:
99.29% (May vary between batches)
CAS Nummer:
[112887-68-0]
Formel:
C21H22N4O6S
Target-Kategorie:
Nucleoside Antimetabolite/Analog,DNA/RNA Synthesis
Anwendungsbeschreibung
Anwendungsbeschreibung:
Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (8.72 mM),H2O:< 1 mg/mL (insoluble or slightly soluble),Ethanol:< 1 mg/mL (insoluble or slightly soluble),DMSO:123 mg/mL (268.27 mM)
